Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-30
2005-08-30
Owens, Amelia A. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S270000
Reexamination Certificate
active
06936723
ABSTRACT:
The present invention provides compounds having improved stability over that of natural benzolactones, and a process for synthesizing these compounds. These compounds exhibit anti-cancer activity and inhibit V-ATPase activity.
REFERENCES:
patent: 5936100 (1999-08-01), Fürstner et al.
patent: 9905136 (1999-02-01), None
patent: 9947523 (1999-09-01), None
patent: 0051589 (2000-08-01), None
Boyd MR, Farina C, Belfiore P, Gagliardi S, Kim JW, Hayakawa Y, Beutler JA, McKee TC, Bowman BJ, Bowman EJ (2001). Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-ATPases.J. Pharmacol. Exp. Ther.297(1):114-120.
Jansen R, Kunze B, Reichenbach H, Höfle G (2000). Antibiotics from gliding bacteria, LXXXVI. Apicularen A and B, cytotoxic 10-membered lactones with a novel mechanism of action fromChondromycesspecies (Myxobacteria): isolation, structure elucidation, and biosynthesis.Eur. J. Org. Chem.2000:913-919.
Snider BB, Song F (2000). Synthesis of the N-((1E)-alkenyl)-(2Z,4Z)-heptadienamide side chain of salicylihalamide A and apicularens A and B.Org. Lett.2(3):407-408.
Ackermann L, Fürstner A, Weskamp T, Kohl FJ, Herrmann WA (1999). Ruthenium carbene complexes with imidazolin-2-ylidene ligands allow the formation of tetrasubstituted cycloalkenes by RCM.Tet. Lett.40:4787-4790.
Huang J, Stevens ED, Nolan SP, Petersen JL (1999). Olefin metathesis-active ruthenium complexes bearing a nucleophilic carbene ligand.J. Am. Chem. Soc.121:2674-2678.
Scholl M, Trnka TM, Morgan JP, Grubbs RH (1999). Increased ring closing metathesis activity of ruthenium-based olefin metathesis catalysts coordinated with imidazolin-2-ylidene ligandsTet. Lett.40:2247-2250.
Kunze B, Jansen R, Sasse F, Höfle G, Reichenbach H (1998). Apicularens A and B, new cytostatic macrolides fromChondromycesspecies (Myxobacteria): production, physico-chemical and biological properties.J. Antibiot.(Tokyo) 51(12):1075-1080.
McKee TC, Galinis DL, Pannell LK, Cardellina II JH, Laasko J, Ireland CM, Murray L, Capon RJ, Boyd MR (1998). The lobatamides, novel cytotoxic macrolides from Southwestern Pacific tunicates.J. Org. Chem.63:7805-7810.
Erickson KL, Beutler JA, Cardellina II JH, Boyd MR (1997). Saliclylihalamides A and B, novel cytotoxic macrolides from the marine spongeHaliclonasp.J. Org. Chem.62:8188-8192.
Crider BP, Xie XS, Stone DK (1994). Bafilomycin inhibits proton flow through the H+channel of vacuolar proton pumps.J. Biol. Chem.269(26):17379-17381.
Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J. Immunol. Meth.65(1-2):55-63.
Still WC, Kahn M, Mitra A (1978). Rapid chromatographic technique for preparative separations with moderate resolution.J. Org. Chem.43:2923-2925.
Brabander Jef De
Wu Yusheng
Board of Regents , The University of Texas System
Foley & Lardner LLP
Owens Amelia A.
LandOfFree
Synthetic salicylihalamides, apicularens and derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic salicylihalamides, apicularens and derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic salicylihalamides, apicularens and derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3480933